Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients

Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients

Fluoropyrimidine-based chemotherapy is an essential component of systemic chemotherapy for colorectal cancer (CRC). The immune response is implicated in chemotherapy-induced cytotoxicity. Here, we reported an immune risk (Imm-R) model for prognostic prediction in patients receiving fluoropyrimidine-...

Full description

Bibliographic Details
Main Authors: Xianwei Mo, Xiaoliang Huang, Yan Feng, Chunyin Wei, Haizhou Liu, Haiming Ru, Haiquan Qin, Hao Lai, Guo Wu, Weishun Xie, Franco Jeen, Yuan Lin, Jungang Liu, Weizhong Tang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
colorectal cancer
fluoropyrimidine
immune-related-gene
tumor-infiltrating immune cells
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1832347

Internet

http://dx.doi.org/10.1080/2162402X.2020.1832347

Similar Items